SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 104 000 KRW -0.1% Market Closed
Market Cap: 8.1T KRW
Have any thoughts about
SK Biopharmaceuticals Co Ltd?
Write Note

SK Biopharmaceuticals Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SK Biopharmaceuticals Co Ltd
Income from Continuing Operations Peer Comparison

Comparables:
000100
008930
128940
S
000250
C
068760

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
SK Biopharmaceuticals Co Ltd
KRX:326030
Income from Continuing Operations
-â‚©35.4B
CAGR 3-Years
48%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Income from Continuing Operations
â‚©145.9B
CAGR 3-Years
9%
CAGR 5-Years
28%
CAGR 10-Years
5%
Hanmi Science Co Ltd
KRX:008930
Income from Continuing Operations
â‚©116.8B
CAGR 3-Years
56%
CAGR 5-Years
44%
CAGR 10-Years
17%
Hanmi Pharm Co Ltd
KRX:128940
Income from Continuing Operations
â‚©207.2B
CAGR 3-Years
87%
CAGR 5-Years
35%
CAGR 10-Years
15%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Income from Continuing Operations
â‚©723.7m
CAGR 3-Years
N/A
CAGR 5-Years
-46%
CAGR 10-Years
-24%
C
Celltrion Pharm Inc
KOSDAQ:068760
Income from Continuing Operations
â‚©11.5B
CAGR 3-Years
-31%
CAGR 5-Years
N/A
CAGR 10-Years
10%

See Also

What is SK Biopharmaceuticals Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
-35.4B KRW

Based on the financial report for Dec 31, 2023, SK Biopharmaceuticals Co Ltd's Income from Continuing Operations amounts to -35.4B KRW.

What is SK Biopharmaceuticals Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
24%

Over the last year, the Income from Continuing Operations growth was 75%. The average annual Income from Continuing Operations growth rates for SK Biopharmaceuticals Co Ltd have been 48% over the past three years , 24% over the past five years .

Back to Top